J Neuroimmunol 2002 Jan;122(1-2):125-131
Sorensen TL, Roed H, Sellebjerg F.
The MS Clinic, Department of Neurology, University of Copenhagen, Glostrup Hospital, 2600 Glostrup, Denmark
We investigated the B-cell expression of chemokine receptors CXCR3, CXCR5 and CCR5 in the blood and cerebrospinal fluid (CSF) from patients in relapse of multiple sclerosis (MS) and in neurological controls.
Chemokine receptor expression was also studied in interferon-beta-treated patients with relapsing-remitting or secondary progressive MS.
We observed significantly higher expression of CXCR3 on B cells in the CSF in active MS than in controls.
Patients with active MS also had higher B-cell expression of CCR5 in blood.
No major differences between RRMS
and SPMS patients were detected, and chemokine receptor expression was
not affected by interferon-beta treatment.
PMID: 11777551 [PubMed - as supplied
PMID: 11777551 [PubMed - as supplied by publisher]